Recent reports have indicated that cholesterol-dependent association of tryptophan-aspartate containing coat protein (TACO) plays a crucial role in the entry/survival of Mycobacterium tuberculosis within human macrophages. Keeping this in view, the present study explored whether the molecules that have the ability to downregulate TACO gene transcription could also restrict entry/survival of mycobacteria within human macrophages. The study revealed that chenodeoxycholic acid (CDCA), either alone or in combination with retinoic acid (RA), had the inherent capacity to downregulate TACO gene transcription in a dose-dependent fashion. This result was in conformity with the existence of a functional FXR/RXR binding site analyzed in the regulatory region of the TACO gene. Furthermore, we demonstrate that the entry and intracellular survival of M. tuberculosis is significantly restricted in THP-1 macrophages exposed to CDCA/RA. On the basis of these findings, we propose that the CDCA/RA-dependent pathway may open a new possibility for the treatment of tuberculosis.
Introduction
Mycobacterium tuberculosis is not only known to parasitize macrophages but also blocks the maturation of its vacuoles from early to late endosomal/lysosomal pathway responsible for degradation of all endocytosed microbes [1] . One of the key events in the maturation process of phagosomes is their progressive acidification within their lumen [2, 3] . Pathogenic mycobacteriumcontaining vacuoles exhibit limited acidification because of their ability to inhibit vacuolar proton-ATPase activity [4, 5] coupled with exclusion of the Rab7 protein that facilitates fusion of endosomes to lysosomes [6] . A host gene coding for tryptophan-aspartate containing coat protein (TACO), also known as coronin-1 in mouse, plays a key role in imparting this Ônon-fusogenicÕ property to Ômycobacterial phagosomesÕ and thus the intracellular survival of the pathogen [7] . In contrast, it has been reported that phagosomes containing less than five bacteria are unable to retain TACO/coronin-1, whereas phagosomes containing more than five bacteria conspicuously retain TACO/coronin-1 within their membrane [8] . TACO/coronin-1 is an actin-binding protein believed to be involved in promoting cytoskeletal remodeling of plasma membrane surfaces and phagosomal biogenesis in mammals [9] . A new dimension was added to this phenomenon by the observation that cellular cholesterol not only dictates the association of TACO/ coronin-1 protein with phagosomal membrane, but also facilitates the entry of mycobacteria within macrophages [10] . This role of cholesterol was further strengthened by the observation that TACO/coronin-1 gene transcription was enhanced by the activation of cholesterol specific receptor-C k [11] . The present study addressed the question of whether, apart from cholesterol, other isoprenoids derived from the mevalonate pathway have the ability to downregulate TACO/coronin-1 gene transcription coupled with effect on mycobacterial entry/survival within macrophages.
Materials and methods

Cells and materials
THP-1 and Jurkat cell lines were obtained from the National Centre for Cell Science (NCCS), Pune. Virulent mycobacterial strain H37Rv was obtained from the Department of Medical Microbiology, Postgraduate Institute of Medical Education and Research, Chandigarh. Various isoprenoids, culture media and fetal bovine serum (FBS) were obtained from Sigma. cDNA synthesis kit was purchased from MBI Fermentas and the PCR core kit from Qiagen. TOPO-reporter kit, Lipofectamine 2000 and b-galactosidase assay kit were purchased from Invitrogen. All other reagents were of the highest quality available. Anti-LAM monoclonal antibody CS-35 was provided by Drs. J.T. Belisle and L. Johnson (Colorado State University, Fort Collins, CO) through NIH, NIAID Contract NO1 AI-75320.
Cell culture, RNA isolation and RT-PCR
Human mononuclear cells from normal subjects were maintained in DulbeccoÕs modified EagleÕs medium (DMEM), 100 U ml À1 pencillin and 100 lg ml À1 streptomycin supplemented with 10% FBS at 37°C under 5% CO 2 -atmosphere. These cells were exposed to either no stimulus or mevastatin (30 lM) or 25-hydroxy cholesterol (1 lM) or lemonene (2.5 lM) or geranylgeraniol (16.2 lM) or testosterone (10 nM) or estradiol (10 nM) or chenodeoxycholic acid (0-300 lM) for 24 h at 37°C in 5% CO 2 -atmosphere. In another experiment, cells were exposed to an increasing concentration of chenodeoxycholic acid (CDCA; 0-100 lM) in the constant presence of retinoic acid (RA; 0.5 lM). At these concentrations, the various stimuli are known to be least toxic while triggering a potent response [12] . Although a concentration of 300 lM for CDCA is not physiologically achievable, a concentration of 250 lM has been used in vitro without any cytotoxic effects [13] .
Before RNA extraction, cell viability was assayed by the Trypan blue dye exclusion method and found to be >95% in all the experiments. Cells from each well were processed for RNA isolation by the acid guanidiumthiocyanate phenol chloroform extraction method [14] .
cDNA was synthesized from total RNA using random hexamer primers and M-MuL V reverse-transcriptase as per manufacturerÕs instructions. The TACO gene was amplified using the primers 5 0 -CCAGTGCTAT-GAGGATGTGCGCG-3 0 and 5 0 -GACACGACTCGC-TTGTCACGGC-3 0 . Invariant control b 2 -microglobulin gene was amplified with primers 5 0 -GAATTGC-TATGTGTCTGGGT-3 0 and 5 0 -CATCTTCAAACCT-CCATGATG-3 0 . These genes were amplified using PCR programs: C-myc gene was amplified with specific primers and cycling conditions as described previously [15] . The primers used span the intronic regions such that amplification from genomic DNA would produce significantly larger DNA products. However, no evidence of genomic DNA contamination was observed. The number of cycles was standardized in preliminary experiments for each gene and care was taken that PCR amplification remained in the linear phase. The PCR products were resolved on 2% agarose gels stained with ethidium bromide. The gels were scanned and the intensity of TACO mRNA was normalized to the b 2 -microglobulin mRNA by densitometry scanning of the photographs using the public domain NIH ImageJ programme (developed at the U.S. National Institutes of Health).
In silico analysis
A 1.6 kb regulatory region at the 5 0 end of the TACO gene transcript was extracted from GenBank DB [16] . The TRANSFAC database was then used to search for FXR/RXR binding sequence using the program MatInspector (release of April, 2004, version 7.2.2 of the genomatix suite) at default parameters; 0.75 threshold for core similarity and optimized threshold for matrix similarity [17, 18] .
Transfection and reporter assay
Transfection and reporter assays were undertaken as previously described [19] . The FXR/RXR response element ÔGGATCACTCTGTCCÕ present in the TACO gene promoter and the c-myc response sequence ÔGTCACGTGCCTTÕ were incorporated in the TOPO vector with the help of TOPO-cloning reaction as per manufacturerÕs instruction. TOPO-vector (without insert) was used as a control. Jurkat cells were seeded at the desired density in DMEM media and the above-mentioned vector was transfected using Lipofectamine 2000. The cells were then treated with a combination of 100 lM CDCA and 0.5 lM RA. 72 h post-transfection, the cells were lysed by three freeze-thaw cycles and clarified supernatant was assayed for b-gal reporter activity. The experiment was repeated three times and the results are represented as relative b-gal activity.
Monolayer culture and treatment
THP-1 cells were seeded into tissue culture plates containing sterile glass coverslips at the desired density in a total volume of 3.5 ml. The monocytes were then induced to become macrophages by incubation with 16 nM of PMA (phorbol 12-myristate 13-acetate) for 16-18 h in DMEM supplemented with 10% heat inactivated FBS at 37°C in 5% CO 2 atmosphere [8] . The purity of macrophages was checked by giemsa staining. Macrophages on the coverslips were treated for 24 h either with (i) a combination of CDCA/RA before mycobacterial infection or (ii) CDCA/RA after infection with mycobacteria. In both conditions, CDCA and RA were used at a concentration of 100 and 0.5 lm, respectively.
Invasion assay
Prior to invasion assays, the medium overlaying the macrophage cultures was replaced with 3.5 ml of prewarmed tissue culture media containing no antibiotics or FBS. M. tuberculosis virulent strain H37Rv was then added to macrophage monolayers in each well for 2 h at 37°C, to obtain a multiplicity of infection (MOI) of 10:1. Assays were terminated by washing once with PBS and replacing the overlying medium supplemented with 100 lg ml À1 of gentamicin. Gentamicin, an aminoglycoside antibiotic, kills extracellular bacteria while intracellular bacteria remain viable [20] . After a 2 h incubation with gentamicin at 37°C in a 5% CO 2 incubator, the cell monolayers were washed once with PBS and processed for immunolabeling as described below.
Immunoflourescent labeling and enumeration of intracellular bacteria
At each measurement time point, the control and CDCA/RA-treated coverslips were removed from tissue culture wells and washed three times with PBS. Cells on the coverslips were then fixed and permeabilized for 20 min with 4% paraformaldehyde/0.1% Triton X-100 in PBS. Primary antibody against lipoarabinomannan (LAM), a major component of the outer surface of mycobacteria, was then added at an appropriate dilution (1:1500) in PBS for 1 h at 37°C. Monolayers were then washed three times in PBS and then overlaid with FITC-labeled anti-mouse IgG, diluted 1:50 in PBS, for 1 h at 37°C [21, 22] . The cells were again rinsed with PBS and then mounted in 50% glycerol in PBS. Coverslips were sealed onto slides with nail polish and visualized immediately. The slides were examined with a fluorescent microscope (Carl Zeiss, Germany) and recorded by a CCD camera. To quantify bacterial uptake and survival, 100 macrophages were selected randomly for each experiment. The results are shown as percentage LAM fluorescence (indicating number of bacteria present) ± standard deviation. Each experiment was performed at least three times. A duplicate set of this experiment was performed and viable M. tuberculosis were enumerated by colony counting (CFU) as described previously [23] . The experiment was repeated at least three times and results represented as percent survival ± standard deviation. CDCA/RA was tested to confirm whether it directly inhibits H37Rv bacilli by adding it at appropriate concentration in 7H9 medium (supplemented with 10% ADC and 2 ml l À1 glycerol) inoculated with the bacilli and observing whether the bacilli growth was inhibited over a 48 h period.
Results
CDCA/RA inhibits TACO gene transcription
To identify molecules that could downregulate TACO gene expression, we used various isoprenoids (derived from the mevalonate pathway), to evaluate their effect on transcriptional expression of the TACO gene. Exposure of mononuclear cells to either mevastatin (HMG-CoA reductase inhibitor) or 25-hydroxycholesterol (HMG-CoA reductase inhibitor and LXR-a agonist) or lemonene (farnesyl transferase inhibitor) resulted in a marginal increase in TACO gene transcription as compared to that in control cells, whereas cells exposed to testosterone showed a marginal decrease (Fig. 1) . However, neither geranylgeraniol (LXR-a antagonist) nor 17b-estradiol had any effect on TACO gene transcription as compared to that in control cells (Fig. 1) . Further, exposure of these cells to CDCA (a potent activator of farnesoid-X-receptor) resulted in dosedependent significant downregulation of TACO gene transcription (Fig. 2) . Similarly, a significant dosedependent decrease (>50%) was observed when cells were exposed to a combination of CDCA and RA (Fig. 3) .
FXR/RXR regulatory sequence is present upstream of TACO gene
Since CDCA and RA in combination act through transcription factor FXR/RXR, we used the MatInspector program that scans potential binding sequences of transcription factors in the TRANSFAC database and found a putative FXR/RXR binding sequence in the regulatory region of the TACO gene (Fig. 4(a) ). To test whether this sequence is functional, we performed a b-gal reporter assay in the Jurkat T-cell line. Our investigations revealed that Jurkat cells show intrinsic c-myc gene expression (Fig. 4(b) ). A b-gal reporter construct, carrying c-myc coupled with FXR/RXR response sequence, was transfected into these cells. CDCA/RA treatment of these cells resulted in a greater than 7-fold decrease in its activity as compared to control cells (Fig. 4(c) ). phages, the cells were incubated with CDCA/RA for 24 h and then infected with live M. tuberculosis H37Rv at a MOI of 10:1 (Figs. 5(a) and 6(a) ). Using fluorescent microscopy to detect FITC-labeled mycobacterial LAM (indicating number of mycobacteria present), we noted that the number of bacteria decreased by more than 20% in these cells. However, following 12 h of infection with H37Rv, less than 50% of bacteria were observed as compared to that in the control cells (Fig. 5(a) ). Further, to investigate the survival of M. tuberculosis when the TACO gene is downregulated, live M. tuberculosis H37Rv-infected THP-1 macrophages were exposed to CDCA/RA for 24 h (Figs. 5(b) and 6(b) ). As shown in Fig. 5(b) , only 65% of bacteria were observed till 24 h. At 48 h of infection, the number decreased significantly to 44% as compared to that in control cells (Fig. 5(b)) . Surprisingly, colony counting (CFU) of the above-mentioned experiments revealed that CDCA/RA treated cultures show no viable growth at any given time point as compared to control cultures ( Fig. 6(a) and (b) ). To unambiguously confirm that the observed effect is not because of CDCA/RA effect on mycobacterial viability per se, we incubated these compounds with free growing bacteria. The results of such an experiment (Fig. 7) confirmed that the inhibition of mycobacterial growth observed within macrophages is because of TACO gene downregulation within these cells.
Discussion
Global concern about tuberculosis has resulted in a lot of investigations to understand why M. tuberculosis, which can survive and replicate extracellularly, has evolved multiple mechanisms to gain entry to the intracellular environment within macrophages equipped with reactive oxygen and nitrogen intermediates that are meant to kill it [24, 25] . A new dimension was added to this research by the finding that cholesterol plays a crucial role not only in the entry of mycobacteria into macrophages, but also mediates the phagosomal association of TACO (tryptophan-aspartate containing coat protein)/coronin-1 that prevents degradation of mycobacteria within lysosomes [10, 26, 27] . It is in this context that the results reported here assume importance. Out of the entire mevalonate pathway-derived isoprenoids which we studied (Fig. 1) , only CDCA showed a significant downregulatory effect upon TACO gene transcription (Fig. 2) . It is pertinent to note that CDCA has been shown to regulate a number of genes either alone, through farnesoid-X-receptor (FXR), or in combination with its heterodimeric partner retinoid-X-receptor (RXR) [28, 29] . To further support these findings, CDCA and RA were used in combination and it was observed that the dose-dependent decrease in TACO gene transcription was even more pronounced and the use of RA showed a decrease in the concentration of CDCA required to inhibit TACO expression ( Fig.  3(a) ). In this same set of experiments, RA alone (negative control) increased TACO gene expression by 2-fold ( Fig. 3(b) ). This raises the possibility that CDCA and RA, when used in combination, show a synergistic effect by activating ligand dependent heterodimeric complex FXR/RXR. CDCA activated FXR has been shown to modulate the transcription of many target genes, including I-BABP, SHP, PLTP and Apo C-II, in association with its heterodimeric partner RXR [28] . The transcriptional regulation of the TACO gene by the FXR/RXR pathway is further supported by the in silico analysis of the FXR/RXR response element in the 5 0 end of the TACO gene (Fig. 4(a) ). In order to unambiguously prove that CDCA/RA downregulates TACO gene transcription through the FXR/RXR response element, we employed an archetype cellular model (Jurkat T-cells) that shows intrinsic c-myc gene expression (Fig. 4(b) ) and a b-gal reporter plasmid containing c-myc coupled with FXR/RXR response element. It is pertinent to note that CDCA/RA treatment of these transfected cells resulted in a 7-fold decrease in b-galactosidase activity as compared to controls (Fig. 4(c) ), thereby proving beyond reasonable doubt that the FXR/RXR response element is involved in CDCA/RA-dependent downregulation of TACO gene transcription. We have also recently identified that vitamin D and RA synergistically downregulate TACO gene expression in human mononuclear cells [30] . This result is in conformity with the in silico analysis of VDR/RXR transcriptional control sites present in the regulatory region of the TACO gene transcript (Fig. 4(a) ). The concept of the study is further supported with mycobacterial entry and survival experiments studied in human macrophage cell line exposed to a combination of CDCA and RA (Figs. 5 and 6 ). When these experiments were performed to detect LAM using monoclonal antibody, we observed that after infection with M. tuberculosis virulent strain H37Rv, the percent LAM fluorescence (indicating number of bacteria present) was reduced to less than half over a period of 12 h (Fig. 5(a) ). Similar results were observed over a period of 48 h when H37Rv-infected THP-1 cells were exposed to CDCA and RA (Fig. 5(b) ). However, when the colony counting of these cultures was observed by the CFU method we detected no viability of M. tuberculosis at any time point (Fig. 6(a) and (b) ). This apparent discrepancy between the results concerning survival of mycobacteria within macrophages revealed by LAM-flourescence and CFU data can be appreciated if one considers the possibility that macrophages can retain some amount of LAM protein even after the bacteria are either dead or partially degraded by lysosomes. Taken together, our results suggest that the suppression of TACO gene expression either prior to or after infection inhibits the entry and intracellular survival of M. tuberculosis. Consequently, there is a reason to believe that CDCA/RA-dependent FXR/RXR pathway may have an important therapeutic implication in the control of M. tuberculosis infection.
